Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine infusion versus opioid-based anesthesia for postoperative pain and nausea/vomiting after inguinal hernia surgery
IRCT20220429054694N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine and remifentanil in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Postoperative pain intensity at 24 hours and Postoperative nausea and vomiting score at 24 hours. Started Dec 2024; status: completed.
02
Drugs
dexmedetomidineremifentanil
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20220429054694N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220429054694N2.